Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Glia. 2022 Mar 17;70(8):1554–1580. doi: 10.1002/glia.24168

BOX 1.

Select unresolved questions

graphic file with name nihms-1811434-t0001.jpg Overall
  • How do astrocytes integrate and respond to diverse molecular signals in their extracellular environment at the cellular and population level?

  • How do they convert this task- and animal state-dependent information into functional outputs that modulate neural circuit structure or function on various temporal and spatial scales?

  • Does this influence on neurons serve homeostatic functions, augment/complement neural circuit properties, or both?

  • Do astrocytes perform similar computations in different brain and spinal cord regions?

  • Do astrocytes temporally hold/store information and, if so, for what purpose?

graphic file with name nihms-1811434-t0002.jpg Indicators
  • What new or improved indicators are needed to address the above questions (e.g., for neuropeptides, neuroactive substances, ions, transcriptional processes, synapse interactions)?

  • How can current limitations to multiplex measurements be overcome (e.g., indicator signal-to-noise ratio, spectral variants, interference with endogenous signaling, buffering effects)?

graphic file with name nihms-1811434-t0003.jpg Actuators
  • Given astrocytes’ complex spatiotemporal signals, how can physiologically meaningful regulation be achieved?

  • Which approaches allow astrocyte “inhibition” at high spatial and temporal resolution?

  • Which astrocyte signaling mechanisms other than calcium control neural circuit function and animal behavior on different timescales (e.g., K+, Na+, cAMP)?

graphic file with name nihms-1811434-t0004.jpg Genetic targeting approaches
  • What genetic (or other) approaches allow targeting functionally homogeneous astrocyte populations for interrogating their function?

  • What approaches allow circuit-specific astrocyte targeting?

graphic file with name nihms-1811434-t0005.jpg Behavioral assays
  • How can quantitative behavioral assays be used to understand better astrocyte signal integration in vivo (e.g., noradrenergic, cholinergic, and dopaminergic signaling)?

  • How can these assays be used to uncover astrocyte effects on neural circuit function in vivo (e.g., leveraging astrocytes’ refractory period-dependent excitation)?

graphic file with name nihms-1811434-t0006.jpg Computational approaches
  • What molecular, structural, or gene expression changes should be measured to understand better astrocytes’ signal integration (with existing or novel indicators)?

  • How do astrocytes control (directly or indirectly) neural circuit properties on various spatial and temporal scales (e.g., spike frequency, synchrony, oscillations, excitation-inhibition balance)?

  • How is astrocytes’ structural and functional heterogeneity relevant to neural circuit operation?

  • How can modeling help predict circuit functions of astrocytes unique to humans?

graphic file with name nihms-1811434-t0007.jpg Astrocyte heterogeneity
  • How does astrocyte heterogeneity at the synaptic, cellular, circuit, and systems levels influence neural circuit function?

  • What intrinsic and environmental factors determine this heterogeneity in health and disease?

graphic file with name nihms-1811434-t0008.jpg Astrocyte metabolism
  • How do astrocyte-derived metabolites (e.g., lactate) regulate neural circuit function and animal behavior?

  • How does altered metabolism in astrocyte-neuron assemblies influence neural circuit function and animal behavior?

graphic file with name nihms-1811434-t0009.jpg Contribution of other non-neuronal cells
  • To what extent does astrocyte modulation of neural circuit function rely on other non-neuronal cells?

  • How do these cells modulate astrocyte-neuron communication in health and disease?

  • How do these cells influence neuronal circuit function directly?

graphic file with name nihms-1811434-t0010.jpg Disease
  • How does disruption of astrocyte-neuron communication contribute to disease onset or progression?

  • How does astrocyte heterogeneity or diversity relate to disease phenotype?